Table 2 Comparation of clinical, pathological and treatment related variables of patients with positive and negative MRI. Univariate analysis
From: Pelvic MRI findings in relapsed prostate cancer after radical prostatectomy
ALL | MR - | MR + | P* | |
|---|---|---|---|---|
n = 70 (%) | n = 37 (%) | n = 33 (%) | ||
PSA (ng/ml) (median) | 7.8 | 7.8 | 7.75 | 0.120 |
Pathologic stage | 0.256 | |||
pT2 | 40 (57) | 23 (33) | 17 (24) | |
pT3 | 30 (43) | 14 (20) | 16 (23) | |
Lymph nodes (20) | 0.215 | |||
pN0 | 17 (85) | 12 (60) | 5 (25) | |
pN1 | 3 (15) | 1 (5) | 2 (10) | |
Gleason score | 0.527 | |||
≤ 7 | 48 (68) | 25 (35) | 23 (33) | |
> 7 | 22 (32) | 12 (17) | 10 (15) | |
Bladder neck involved (67) | 0.382 | |||
Yes | 7 (10) | 3 (4) | 4 (6) | |
No | 60 (90) | 34 (51) | 26 (39) | |
Lymphatic vessel invasion | 0.249 | |||
Yes | 4 (6) | 3 (4) | 1 (2) | |
No | 2 (3) | 2 (3) | 0 (0) | |
Unknown | 64 (91) | 32 (45.5) | 32 (45.5) | |
Positive margins | 0.510 | |||
Yes | 40 (57) | 21 (30) | 19 (27) | |
No | 30 (43) | 16 (23) | 14 (20) | |
Lymphadenectomy | 0.092 | |||
Yes | 20 (29) | 13 (19) | 7 (10) | |
No | 50 (71) | 24 (34) | 26 (37) | |
Radical prostatectomy | 0.312 | |||
Open | 20 (29) | 12 (17) | 8 (12) | |
Laparoscopy/Robotic | 50 (71) | 25 (35.5) | 25 (35.5) | |
N-V bundle preservation | 0.223 | |||
Yes | 32 (46) | 19 (27) | 13 (19) | |
No | 38 (54) | 18 (26) | 20 (28) | |
*PSA diagnostic (ng/ml) | 0.630 | |||
Median | 7.77 (3.98–58.63) | 7.77 (3.98–58.63) | 7.75 (4.1–32) | |
*Nadir postop PSA (ng/ml) | 0.101 | |||
Median | 0.00 (0.00–6.68) | 0.00 (0.00–0.70) | 0.01 (0.00–6.68) | |
*PSA at recurrence (ng/ml) | 0.737 | |||
Median | 0.38 (0.00–8.05) | 0.41 (0.00–1.13) | 0.37 (0.15–8.05) | |
*PSADT (months) | 0.446 | |||
Median | 1.62 (0.67–153.24) | 14.64 (0.67–49.95) | 8.18 (2.48–145.2) |